Lung Regeneration
Post-trauma Lung Damage/Fibrosis
ResearchActive
Key Facts
About Pandorum Technologies
Pandorum Technologies is a private, preclinical-stage biotech firm founded in 2011 and based in San Francisco, operating at the intersection of tissue engineering and regenerative medicine. Its core technology platform integrates bio-materials, cellular engineering, exosome/nanotherapy, and bio-fabrication techniques to build functional human tissues. The company's pipeline is led by a bio-engineered cornea product aimed at treating corneal disorders, supported by a mini-liver platform for drug discovery and an early-stage lung regeneration program. Pandorum is approaching clinical-stage development and has gained recognition in startup competitions and media lists.
View full company profile